Related Experiment Videos
Quantitative in vitro bioassay for recombinant human interleukin-11.
H Yokota1, M Kishimoto, H Saito
1Yamanouchi Pharmaceutical Co., Ltd, Tsukuba-shi, Japan.
Journal of AOAC International
|October 26, 2000
Summary
A new bioassay accurately measures recombinant human interleukin-11 (rhIL-11) activity using T10 cell proliferation. This simple, reproducible method enhances quality control for rhIL-11 production.
Area of Science:
- Biotechnology
- Cell Biology
- Immunology
Background:
- Recombinant human interleukin-11 (rhIL-11) is a therapeutic protein requiring precise activity measurement.
- Existing bioassays may lack simplicity or reproducibility for routine quality control.
Purpose of the Study:
- To develop and validate a cell culture-based in vitro bioassay for quantifying rhIL-11 biological activity.
- To establish a reliable method for rhIL-11 quality control.
Main Methods:
- Utilized T10 cells, derived from the T1165 murine plasmacytoma line, for the bioassay.
- Employed WST-1 (tetrazolium compound) for colorimetric detection of cell proliferation.
- Optimized microplate layout by interleaving and alternating sample/standard positions across two plates to improve precision.
Main Results:
- The bioassay demonstrated high precision, with a coefficient of variation below 8%.
- The optimized microplate positioning significantly improved assay reproducibility.
- The method proved accurate and suitable for quality control applications.
Conclusions:
- A robust and reproducible in vitro bioassay for rhIL-11 activity has been established.
- This method offers a simple, accurate, and reproducible approach for rhIL-11 quality control.
- The developed bioassay supports the reliable production of rhIL-11.